Baron Silver Stevens Financial Advisors, LLC Gilead Sciences, Inc. Transaction History
Baron Silver Stevens Financial Advisors, LLC
- $587 Million
- Q4 2024
A detailed history of Baron Silver Stevens Financial Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baron Silver Stevens Financial Advisors, LLC holds 6,849 shares of GILD stock, worth $737,294. This represents 0.11% of its overall portfolio holdings.
Number of Shares
6,849
Previous 6,849
-0.0%
Holding current value
$737,294
Previous $574,000
10.1%
% of portfolio
0.11%
Previous 0.1%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
2,086Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.4 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.72 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.5 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.24 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...